help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 1, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0179
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/7/2421    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Völzke, H.
Right arrow Articles by Dörr, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Völzke, H.
Right arrow Articles by Dörr, M.
Related Collections
Right arrow Thyroid
Right arrow Cardiovascular Endocrinology

Submitted on January 24, 2007
Accepted on April 23, 2007

THE RELATION OF THYROID DYSFUNCTION WITH ALL-CAUSE AND CIRCULATORY MORTALITY: IS THERE A CAUSAL RELATIONSHIP?

Henry Völzke, Christian Schwahn, Henri Wallaschofski, and Marcus Dörr*

Institute of Epidemiology and Social Medicine, Department of Gastroenterology, Endocrinology, and Nutrition, Department of Cardiology, University of Greifswald, Germany

* To whom correspondence should be addressed. E-mail: voelzke{at}uni-greifswald.de.

Context. Currently, there is ongoing debate on whether subclinical and overt thyroid dysfunction may exert deleterious effects on the cardiovascular system with the consequence of increased mortality in affected individuals. We systematically review studies on the relation of thyroid dysfunction with all-cause and circulatory mortality questioning whether thyroid dysfunction is a causal factor for mortality.

Methods. Two investigators independently searched the MEDLINE database. All case-control and cohort studies published in peer-reviewed journals were selected. Studies on non-thyroidal illness or low-T3 syndrome and reports from highly selected populations were not considered. Risk estimates from studies with appropriate adjustment for confounders were meta-analysed.

Results. Four among eight studies performed to investigate the association between hyperthyroidism and mortality revealed an increased risk of either all-cause or circulatory mortality. Only the minority of studies, however, adjusted analyses for relevant confounders besides age, sex, and race. Studies following radioiodine therapy were generally biased by indication. Findings from eleven studies that investigated the relation between hypothyroidism and mortality were highly discrepant and partly even mutually exclusive. Some of these discrepancies are explained by confounding and selection.

Conclusions. The currently available evidence for a causal relation of both hyperthyroidism and hypothyroidism with mortality is weak and should particularly not be used to decide whether or not patients with subclinical thyroid conditions should be treated. Very old individuals might represent an exception from this rule and may benefit from mildly reduced thyroid function, but this has to be substantiated by further research.


Key words: hyperthyroidism • hypothyroidism • cardiovascular system • mortality




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
P. Haentjens, A. Van Meerhaeghe, K. Poppe, and B. Velkeniers
Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies
Eur. J. Endocrinol., September 1, 2008; 159(3): 329 - 341.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. Biondi
Should we treat all subjects with subclinical thyroid disease the same way?
Eur. J. Endocrinol., September 1, 2008; 159(3): 343 - 345.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Mariotti
Mild Hypothyroidism and Ischemic Heart Disease: Is Age the Answer?
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2969 - 2971.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Razvi, A. Shakoor, M. Vanderpump, J. U. Weaver, and S. H. S. Pearce
The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2998 - 3007.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. Ochs, R. Auer, D. C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, and N. Rodondi
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ann Intern Med, June 3, 2008; 148(11): 832 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. N. Pearce, P. W. F. Wilson, Q. Yang, R. S. Vasan, and L. E. Braverman
Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 888 - 894.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. C. Ridgway, Y. Tomer, and S. M. McLachlan
Update in Thyroidology
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3755 - 3761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society